Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 4 Suppl 3 (Suppl 3), S265-72

Epidemiology and Genetics of Rheumatoid Arthritis

Affiliations
Review

Epidemiology and Genetics of Rheumatoid Arthritis

Alan J Silman et al. Arthritis Res.

Abstract

The prevalence of rheumatoid arthritis (RA) is relatively constant in many populations, at 0.5-1.0%. However, a high prevalence of RA has been reported in the Pima Indians (5.3%) and in the Chippewa Indians (6.8%). In contrast, low occurrences have been reported in populations from China and Japan. These data support a genetic role in disease risk. Studies have so far shown that the familial recurrence risk in RA is small compared with other autoimmune diseases. The main genetic risk factor of RA is the HLA DRB1 alleles, and this has consistently been shown in many populations throughout the world. The strongest susceptibility factor so far has been the HLA DRB1*0404 allele. Tumour necrosis factor alleles have also been linked with RA. However, it is estimated that these genes can explain only 50% of the genetic effect. A number of other non-MHC genes have thus been investigated and linked with RA (e.g. corticotrophin releasing hormone, oestrogen synthase, IFN-gamma and other cytokines). Environmental factors have also been studied in relation to RA. Female sex hormones may play a protective role in RA; for example, the use of the oral contraceptive pill and pregnancy are both associated with a decreased risk. However, the postpartum period has been highlighted as a risk period for the development of RA. Furthermore, breastfeeding after a first pregnancy poses the greatest risk. Exposure to infection may act as a trigger for RA, and a number of agents have been implicated (e.g. Epstein-Barr virus, parvovirus and some bacteria such as Proteus and Mycoplasma). However, the epidemiological data so far are inconclusive. There has recently been renewed interest in the link between cigarette smoking and RA, and the data presented so far are consistent with and suggestive of an increased risk.

Figures

Figure 1
Figure 1
Prevalence of rheumatoid arthritis in various populations. Data from [1-4,6-9,11,12,16,17].
Figure 2
Figure 2
The incidence of rheumatoid arthritis in relation to use of the oral contraceptive pill (OC). Data from the Royal College of General Practioners' oral contraception study [54].
Figure 3
Figure 3
Increased risk of rheumatoid arthritis onset in the postpartum period. * Relative to nonpregnant periods. Data from [59].

Similar articles

See all similar articles

Cited by 163 PubMed Central articles

See all "Cited by" articles

References

    1. Carmona L, Villaverde V, Hernandez-Garcia C, Ballina J, Gabriel R, Laffon A. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology. 2002;41:88–95. doi: 10.1093/rheumatology/41.1.88. - DOI - PubMed
    1. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol. 2000;27:1386–1389. - PubMed
    1. Aho K, Kaipiainen-Seppanen O, Heliovaara M, Klaukka T. Epidemiology of rheumatoid arthritis in Finland. Semin Arthritis Rheum. 1998;27:325–334. - PubMed
    1. Cimmino MA, Parisi M, Moggiana G, Mela GS, Accardo S. Prevalence of rheumatoid arthritis in Italy: the Chiavari study. Ann Rheum Dis. 1998;57:315–318. - PMC - PubMed
    1. Kvien TK, Glennas A, Knudsrod OG, Smedstad LM, Mowinckel P, Forre O. The prevalence and severity of rheumatoid arthritis in Oslo: results from a county register and a population survey. Scand J Rheumatol. 1997;26:412–418. - PubMed
Feedback